Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Merck KGaA
Biotech
Layoffs still battering biotech, with Big Pharmas piling on pain
More companies laid off staff last month than in January 2022, driven by cuts at Big Pharmas and smaller biotechs conducting additional rounds.
Max Bayer
Feb 1, 2023 10:50am
Merck KGaA shrinks US R&D team as layoffs batter industry
Jan 23, 2023 10:00am
Vera finally snags a win for Merck KGaA kidney disease castoff
Jan 3, 2023 4:01pm
Merck KGaA hands over IL-12 cancer med for up to $121M
Jan 3, 2023 2:17pm
Amgen, Merck KGaA tap ADC development spigot with new deals
Dec 27, 2022 1:00pm
Merck KGaA turns to BD to rapidly speed up pipeline progress
Nov 21, 2022 12:00pm
